|
NDUFB7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.277700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.119700E-02 |
| Normal-vs-Stage2 |
5.785000E-01 |
| Normal-vs-Stage3 |
3.864300E-02 |
| Normal-vs-Stage4 |
1.446660E-04 |
| Stage1-vs-Stage2 |
1.640100E-02 |
| Stage1-vs-Stage3 |
9.580200E-01 |
| Stage1-vs-Stage4 |
1.243930E-02 |
| Stage2-vs-Stage3 |
1.479900E-02 |
| Stage2-vs-Stage4 |
4.249600E-04 |
| Stage3-vs-Stage4 |
5.324100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.179100E-03 |
| Normal-vs-AfricanAmerican |
9.657700E-03 |
| Normal-vs-Asian |
1.430010E-01 |
| Caucasian-vs-AfricanAmerican |
4.022400E-01 |
| Caucasian-vs-Asian |
4.057800E-01 |
| AfricanAmerican-vs-Asian |
1.997600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.897600E-02 |
| Normal-vs-Female |
1.684140E-02 |
| Male-vs-Female |
6.050800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.585700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.576380E-02 |
| Normal-vs-Age(61-80Yrs) |
9.198300E-02 |
| Normal-vs-Age(81-100Yrs) |
5.163600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.737800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.859200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.641000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.417400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.689800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.314200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.262400E-01 |
| Classical-VS-Follicular |
2.34099994944614E-09 |
| Classical-VS-Other |
4.255800E-01 |
| Classical-VS-Normal |
1.373890E-04 |
| Tall-VS-Follicular |
1.56719999977462E-07 |
| Tall-VS-Other |
1.773600E-01 |
| Tall-VS-Normal |
5.991100E-04 |
| Follicular-VS-Other |
1.759950E-01 |
| Follicular-VS-Normal |
8.621600E-02 |
| Other-VS-Normal |
4.709200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.484400E-01 |
| Normal-vs-N1 |
6.705800E-02 |
| N0-vs-N1 |
1.208150E-01 |
|
|
